Skip to main content
. 2008 Jul 30;102(11):1575–1580. doi: 10.1016/j.rmed.2008.06.006

Table 2.

Patient medication

Measurement Patient group
Exacerbated COPD Stable COPD Non-obstructed smokers
No. patients 136 68 16
Short acting β2 agonist 80 40 0
Long acting β2 agonist 57 42 0
Inhaled steroid 94 53 0
Inhaled steroid (BDP) 1040 ± 727 949 ± 588
Oral theophylline 45 23 0
Theophylline (mg) 482 ± 189 524 ± 198
Nebulised therapy 86 28 0
Home oxygen 39 11 0
Maintenance oral steroids 9 6 0